Omada Health is trading at $19.96, up 6.91%, with the reason for the after-hours rise unconfirmed.
- The company’s official investor news page lists a scheduled November 5 third-quarter results announcement, not a new October 15 catalyst.
- An October 14 report also noted no clear company-specific catalyst.
- Major indexes were mixed in the supplied market context, but the evidence does not establish a broader-market cause.